Literature DB >> 17097148

The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression.

Sang K Kim1, Raymond F Novak.   

Abstract

Endogenous factors, including hormones, growth factors and cytokines, play an important role in the regulation of hepatic drug metabolizing enzyme expression in both physiological and pathophysiological conditions. Diabetes, fasting, obesity, protein-calorie malnutrition and long-term alcohol consumption produce changes in hepatic drug metabolizing enzyme gene and protein expression. This difference in expression alters the metabolism of xenobiotics, including procarcinogens, carcinogens, toxicants and therapeutic agents, potentially impacting the efficacy and safety of therapeutic agents, and/or resulting in drug-drug interactions. Although the mechanisms by which xenobiotics regulate drug metabolizing enzymes have been studied intensively, less is known regarding the cellular signaling pathways and components which regulate drug metabolizing enzyme gene and protein expression in response to hormones and cytokines. Recent findings, however, have revealed that several cellular signaling pathways are involved in hormone- and growth factor-mediated regulation of drug metabolizing enzymes. Our laboratory has reported that insulin and growth factors regulate drug metabolizing enzyme gene and protein expression, including cytochromes P450 (CYP), glutathione S-transferases (GST) and microsomal epoxide hydrolase (mEH), through receptors which are members of the large receptor tyrosine kinase (RTK) family, and by downstream effectors such as phosphatidylinositol 3-kinase, mitogen activated protein kinase (MAPK), Akt/protein kinase B (PKB), mammalian target of rapamycin (mTOR), and the p70 ribosomal protein S6 kinase (p70S6 kinase). Here, we review current knowledge of the signaling pathways implicated in regulation of drug metabolizing enzyme gene and protein expression in response to insulin and growth factors, with the goal of increasing our understanding of how disease affects these signaling pathways, components, and ultimately gene expression and translational control.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097148      PMCID: PMC1828071          DOI: 10.1016/j.pharmthera.2006.07.004

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  278 in total

Review 1.  Roles of serine/threonine phosphatases in hippocampal synaptic plasticity.

Authors:  D G Winder; J D Sweatt
Journal:  Nat Rev Neurosci       Date:  2001-07       Impact factor: 34.870

2.  Positive and negative regulation of Raf kinase activity and function by phosphorylation.

Authors:  H Chong; J Lee; K L Guan
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

3.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.

Authors:  Z Han; D L Boyle; L Chang; B Bennett; M Karin; L Yang; A M Manning; G S Firestein
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 4.  Dual specificity phosphatases: a gene family for control of MAP kinase function.

Authors:  M Camps; A Nichols; S Arkinstall
Journal:  FASEB J       Date:  2000-01       Impact factor: 5.191

5.  Involvement of a phosphatidylinositol 3-kinase-p38 mitogen activated protein kinase pathway in antigen-induced IL-4 production in mast cells.

Authors:  N Hirasawa; Y Sato; Y Fujita; K Ohuchi
Journal:  Biochim Biophys Acta       Date:  2000-01-03

6.  Insulin stimulates tyrosine phosphorylation and inactivation of protein-tyrosine phosphatase 1B in vivo.

Authors:  J Tao; C C Malbon; H Y Wang
Journal:  J Biol Chem       Date:  2001-06-06       Impact factor: 5.157

7.  Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase.

Authors:  I Leclerc; C Lenzner; L Gourdon; S Vaulont; A Kahn; B Viollet
Journal:  Diabetes       Date:  2001-07       Impact factor: 9.461

Review 8.  The PI3K-PDK1 connection: more than just a road to PKB.

Authors:  B Vanhaesebroeck; D R Alessi
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

9.  The role of phosphatidylinositol 3-kinase, Src kinase, and protein kinase A signaling pathways in insulin and glucagon regulation of CYP2E1 expression.

Authors:  K J Woodcroft; R F Novak
Journal:  Biochem Biophys Res Commun       Date:  1999-12-20       Impact factor: 3.575

10.  Evidence that 3-phosphoinositide-dependent protein kinase-1 mediates phosphorylation of p70 S6 kinase in vivo at Thr-412 as well as Thr-252.

Authors:  A Balendran; R Currie; C G Armstrong; J Avruch; D R Alessi
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

View more
  40 in total

Review 1.  Hormones and antioxidant systems: role of pituitary and pituitary-dependent axes.

Authors:  A Mancini; R Festa; V Di Donna; E Leone; G P Littarru; A Silvestrini; E Meucci; A Pontecorvi
Journal:  J Endocrinol Invest       Date:  2010-06       Impact factor: 4.256

2.  Effect of a glutathione S-transferase inhibitor on oxidative stress and ischemia-reperfusion-induced apoptotic signalling of cultured cardiomyocytes.

Authors:  E Röth; N Marczin; B Balatonyi; S Ghosh; V Kovács; N Alotti; B Borsiczky; B Gasz
Journal:  Exp Clin Cardiol       Date:  2011

3.  Ovarian expressed microsomal epoxide hydrolase: role in detoxification of 4-vinylcyclohexene diepoxide and regulation by phosphatidylinositol-3 kinase signaling.

Authors:  Poulomi Bhattacharya; Nivedita Sen; Patricia B Hoyer; Aileen F Keating
Journal:  Toxicol Appl Pharmacol       Date:  2011-10-29       Impact factor: 4.219

Review 4.  Altered Transport and Metabolism of Phenolic Compounds in Obesity and Diabetes: Implications for Functional Food Development and Assessment.

Authors:  Benjamin W Redan; Kimberly K Buhman; Janet A Novotny; Mario G Ferruzzi
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

Review 5.  miRNAs: effectors of environmental influences on gene expression and disease.

Authors:  Alice Hudder; Raymond F Novak
Journal:  Toxicol Sci       Date:  2008-02-16       Impact factor: 4.849

6.  Tea polyphenols protect bovine mammary epithelial cells from hydrogen peroxide-induced oxidative damage in vitro.

Authors:  Yanfen Ma; Lei Zhao; Min Gao; Juan J Loor
Journal:  J Anim Sci       Date:  2018-09-29       Impact factor: 3.159

Review 7.  Post-translational and post-transcriptional modifications of pregnane X receptor (PXR) in regulation of the cytochrome P450 superfamily.

Authors:  Tomas Smutny; Sridhar Mani; Petr Pavek
Journal:  Curr Drug Metab       Date:  2013-12       Impact factor: 3.731

8.  Influence of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase II metabolites in the Zucker diabetic fatty rat.

Authors:  Tzu-Ying Chen; Mario G Ferruzzi; Qing-Li Wu; James E Simon; Stephen T Talcott; Jun Wang; Lap Ho; George Todd; Bruce Cooper; Giulio M Pasinetti; Elsa M Janle
Journal:  Mol Nutr Food Res       Date:  2017-08-14       Impact factor: 5.914

9.  Cyclic AMP-dependent protein kinase signaling modulates pregnane x receptor activity in a species-specific manner.

Authors:  Kristin Lichti-Kaiser; Chenshu Xu; Jeff L Staudinger
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

10.  The hyaluronan receptor for endocytosis mediates hyaluronan-dependent signal transduction via extracellular signal-regulated kinases.

Authors:  Svetlana V Kyosseva; Edward N Harris; Paul H Weigel
Journal:  J Biol Chem       Date:  2008-04-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.